logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Public Companies
    • In-depth Analysis
    • Trusted Advisors
      • Mortgage Broker
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • Events
    • GCFF Conference
    • Past GCFF Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Healthcare and Life Sciences in North America: Opportunities & Post-Pandemic Outlook

December 12, 2022

Life Science

细胞与基因疗法

H1 2022 Healthcare and Life Sciences Worldwide: Cell and Gene Therapy (CGT)

December 6, 2022

Life Science

H1 2022 Healthcare and Life Sciences in North America: Market Insights

November 29, 2022

Life Science

think research ceo interview feature image_Website

Digital Solutions and Data Service for Clinicians Worldwide – Think Research

July 19, 2022

Life Science

VolitionRx

VolitionRx: Advancing the science of epigenetics

May 24, 2022

Life Science

Hemostemix PR

Hemostemix Confirms OTCQB Listing

October 28, 2021

Life Science

headway-F2KRf_QfCqw-unsplash

Looking for your next +30% opportunity? Join our multi-sector high growth stock virtual event

October 27, 2021

Cannabis, Consumer Goods, Life Science, Technology

Hemostemix PR

Hemostemix Confirms OTCQB Application is Filed

October 19, 2021

Cannabis, Consumer Goods, Life Science, Technology

Hemostemix PR

Hemostemix Announces Dr. Fraser C. Henderson Sr., MD, as Chief Medical Officer

October 14, 2021

Cannabis, Consumer Goods, Life Science, Technology

Hemostemix PR

Hemostemix Announces the Second Stem Cell Recipient Interview: One Week to No Chest Pain

October 4, 2021

Cannabis, Consumer Goods, Life Science, Technology

2021中国医药创新与投资大会

Insights into China’s Pharmaceutical Industry Trends from a 2,000-strong Industry Conference

September 30, 2021

Life Science

Hemostemix PR

Hemostemix Announces Closing of First Tranche of Unit Private Placement

September 21, 2021

Life Science

Shaping the Future of Medicine: Hemostemix (TSXV: HEM; OTCQB: HMTXF)

September 20, 2021

Life Science

Hemostemix PR

Hemostemix Announces the First of a Series of 2021 Video Interviews with ACP-01 Recipients: What the Successful Compassionate Treatment of Ischemic Cardiomyopathy Looks Like After 13 Years

September 14, 2021

Life Science

Hemostemix PR

Hemostemix Announces Five Million Unit Private Placement

September 8, 2021

Life Science

Hemostemix PR

Hemostemix Provides Update of Phase II Clinical Trial, 9th Circuit Court Decision Including Cost Award and its Annual General Meeting Results

July 6, 2021

Life Science

Hemostemix PR

Hemostemix Announces Warrant Repricing and Extension

July 5, 2021

Life Science

Hemostemix PR

Peter Lacey Increases His Investment in Hemostemix Inc.

June 21, 2021

Life Science

  • 1
  • 2
  • 3
  • 4
  • 5
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2023 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada